Abstract:Objective: To develop a biodegradable implantable bone material with compatible mechanics with the bone tissue, providing a new biomaterial for clinical bone repair and regeneration. Methods: Silk reinforced polycaprolactone composites (SPC) containing 20%, 40%, and 60% silk were prepared by layer-by-layer assembly and hot-pressing technology. Macroscopic morphology was observed and microstructure were observed by scanning electron microscopy, compressive mechanical properties were detected by compression test, surface wettability was detected by surface contact angle test, degradation of materials was observed after soaking in PBS for 180 days, and proliferation of MC3T3-E1 cells was detected by cell counting kit 8 assay. Six Sprague Dawley rats were subcutaneously implanted with polycaprolactone (PCL) and 20%-SPC, respectively. Masson staining was used to analyze the in vivo degradation behavior and vascularization effect within 180 days. Results: The pore defects of the three SPC sections were relatively few. In the range of 20% to 60%, as the silk content increased and the PCL content decreased, the interlayer spacing of silk fabric decreased, and the fibers almost covered the entire cross-section. The compressive modulus and compressive strength of SPC showed an increasing trend, and the compressive modulus of 60%-SPC was slightly lower than that of 40%-SPC. There were significant differences in compressive modulus and compressive strength between the materials ( P<0.05). In vitro simulated fluid degradation experiments showed that the mass loss of the three types of SPC after 180 days of degradation was within 5%, with the highest mass loss observed in 60%-SPC. The differences in mass loss between the materials were significant ( P<0.05). As the silk content increased, the static water contact angle of each material gradually decreased, and all could promote the proliferation of MC3T3-E1 cells. The subcutaneous degradation experiment in rats showed that 20%-SPC began to degrade at 30 days after implantation, and material degradation and vascularization were significant at 180 days, which was in sharp contrast to PCL. Conclusion: SPC has the mechanical and hydrophilic properties that are compatible with bone tissue. It maintains its mechanical strength for a long time in a simulated body fluid environment in vitro, and achieves dynamic synchronization of material degradation, tissue regeneration, and vascularization through the body's immune regulation mechanism in vivo. It is expected to provide a new type of implant material for clinical bone repair.

Bioactivity, Hemocompatibility, and Inflammatory Response of Calcium Incorporated Sulfonated Polyether Ether Ketone on Mouse-derived Bone Marrow Cells

Bioactive Mineralized Small Intestinal Submucosa Acellular Matrix/pmma Bone Cement for Vertebral Bone Regeneration.

Silk Fibroin 3D Microparticle Scaffolds with Bioactive Ceramics: Chemical, Mechanical, and Osteoregenerative Characteristics

Preparation, Characterization, in Vitro Bioactivity, and Cellular Responses to a Polyetheretherketone Bioactive Composite Containing Nanocalcium Silicate for Bone Repair.

The ability of SPEEK to promote the proliferation and osteogenic differentiation of BMSCs on PEEK surfaces

Facile surface functional polyetheretherketone with antibacterial and immunoregulatory activities for enhanced regeneration toward bacterium-infected bone destruction

Bioactive material‑sodium alginate-polyvinyl alcohol composite film scaffold for bone tissue engineering application

Calcium Silicate Whiskers-Enforced Poly(Ether-Ether-Ketone) Composites with Improved Mechanical Properties and Biological Activities for Bearing Bone Reconstruction

Calcium silicate biocomposites: effects of selenium oxide on the physico-mechanical features and their in-vitro biological assessments

Additive manufacturing and in vitro study of biological characteristics of sulfonated polyetheretherketone-bioactive glass porous bone scaffolds

Production and sulfonation of bioactive polyetheretherketone foam for bone substitute applications

The effect of biomimetic coating and cuttlebone microparticle reinforcement on the osteoconductive properties of cellulose-based scaffolds

Surface bioactivation of Polyetheretherketone (PEEK) by magnesium chondroitin sulfate (MgCS) as orthopedic implants for reconstruction of skeletal defects

Influence of Sulfur Content on Bone Formation and Antibacterial Ability of Sulfonated PEEK.

Effect of Surface Modification of PEEK Artificial Phalanx by 3D Printing on its Biological Activity

Macro-mesoporous Composites Containing PEEK and Mesoporous Diopside As Bone Implants: Characterization, in Vitro Mineralization, Cytocompatibility, and Vascularization Potential and Osteogenesis in Vivo.

Exosome-functionalized polyetheretherketone-based implant with immunomodulatory property for enhancing osseointegration

[Physical, chemical, and biological property of silk reinforced polycaprolactone composites for bone tissue engineering]

Surface Modification of Poly(ether ether ketone) by Simple Chemical Grafting of Strontium Chondroitin Sulfate to Improve its Anti‐inflammation, Angiogenesis, Osteogenic Properties

Design and development of biomimetic electrospun sulphonated polyether ether ketone nanofibrous scaffold for bone tissue regeneration applications: in vitro and in vivo study

Enhancing bioactivity and biocompatibility of polyetheretherketone (PEEK) for dental and maxillofacial implants: A novel sequential soaking process